Published Thursday, April 29, 2021 5:06PM EDT Elya Martinson has two important milestones approaching: the anniversary of her cancer diagnosis on Friday, and on Tuesday, the day she d be fully immunized against COVID-19 - if her second vaccine dose is not delayed four months. The single mother of three in Kelowna, B.C., received her first shot of the Pfizer-BioNTech vaccine on April 14, and says she was told at the time she would have to wait until August before booking again, despite having stage 4 lung cancer. Pfizer recommends a 21-day interval between shots of its two-dose vaccine, and like several provinces, British Columbia does not offer medical exemptions for higher risk cancer patients like Martinson.
Adina Bresge
Elya Martinson, shown in this handout image, has two important milestones coming up in her calendar: the anniversary of the appointment that changed everything, and the aspirational date of the appointment that could bring her and her family some measure of security. Friday marks the one-year cancerversary of the day the single mother of three in Kelowna, B.C., learned she had Stage 4 lung cancer, a diagnosis made all the more devastating that the COVID-19 crisis forced her children to stay home from school to shield her from the severe risks of infection.
Image Credit: THE CANADIAN PRESS/HO-Memorable and Vibrant Okanagan Photography
Merck Canada and MaRS Announce Winners of the Lung Cancer Innovation Challenge
News provided by
Share this article
Share this article
Challenge participants presented solutions aimed at improving patient outcomes and reducing time between diagnosis and treatment for lung cancer patients
Challenge winners include
the Kingston Health Sciences Centre and the Princess Margaret Cancer Centre, with solutions to help improve timely access to specialized care in rural South Eastern Ontario and accelerate lung cancer diagnosis and treatment through liquid biopsy
KIRKLAND, QC, April 28, 2021 /CNW/ - Merck Canada and MaRS Discovery District (MaRS) are proud to announce the winners of the Lung Cancer Innovation Challenge: the Kingston Health Sciences Centre (KHSC), competition winner and the Princess Margaret Cancer Centre, runner up winner. The competition, which launched in January 2021, challenged Ontario-based innovators to identify, implement and scale solutions that could help
Adina Bresge
Elya Martinson, shown in this handout image, has two important milestones coming up in her calendar: the anniversary of the appointment that changed everything, and the aspirational date of the appointment that could bring her and her family some measure of security. Friday marks the one-year cancerversary of the day the single mother of three in Kelowna, B.C., learned she had Stage 4 lung cancer, a diagnosis made all the more devastating that the COVID-19 crisis forced her children to stay home from school to shield her from the severe risks of infection. THE CANADIAN PRESS/HO-Memorable and Vibrant Okanagan Photography
Article content
The Winnipeg Regional Health Authorityâs new president and CEO brings more than 30 years of health care operations experience to his new role.
The WHRAâs board of directors announced that Mike Nader will take over leadership of the health authority on May 17.
We apologize, but this video has failed to load.
Try refreshing your browser, or New WRHA CEO ready to help âprotect the health of Manitobansâ Back to video
Nader has served in executive management roles with public health care systems in British Columbia and Ontario. Most recently, he served as the Chief Transformation Officer at Ontario Health, with responsibility for leading the transition of 20 provincial agencies and local health integration networks into a single provincial agency.